Share This Blog
Facebook
Top Posts
- Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program
- Excel Diagnostics and Nuclear Oncology Center Selected For New Investigational PRRT Treatment and Gallium Scan for Carcinoid and Neuroendocrine Tumor Patients
- FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
- Two Lung Carcinoid Survivors Inspire and Lead the Way
- FDA Approves Amendment for PRRT Clinical Trial in Texas
Archives
- May 2013 (2)
- April 2013 (1)
- March 2013 (4)
- February 2013 (3)
- January 2013 (4)
- December 2012 (7)
- November 2012 (3)
- October 2012 (1)
- September 2012 (1)
- August 2012 (3)
- July 2012 (3)
- June 2012 (2)
- May 2012 (3)
- April 2012 (3)
- March 2012 (3)
- February 2012 (3)
- January 2012 (3)
- December 2011 (4)
- November 2011 (4)
- October 2011 (2)
- September 2011 (1)
- August 2011 (6)
- July 2011 (5)
- June 2011 (6)
- May 2011 (3)
- April 2011 (5)
- March 2011 (4)
- February 2011 (1)
- January 2011 (11)
- December 2010 (1)
- November 2010 (6)
- October 2010 (6)
- September 2010 (6)
- August 2010 (6)
- July 2010 (6)
- June 2010 (6)
- May 2010 (8)
- April 2010 (9)
- March 2010 (12)
- February 2010 (11)
- January 2010 (12)
- December 2009 (4)
- November 2009 (1)
- October 2009 (3)
Blogroll
- whydotpharma explores how pharma companies can improve their patient focus via social media.
Carcinoid Cancer Foundation
- Carcinoid Cancer Foundation The premiere resource, nationally and internationally, for current and comprehensive carcinoid and neuroendocrine tumor information.
E-lists
Facebook
- CCF's Facebook Page Visit us on Facebook and meet others from the carcinoid/NET community.
Pharma Companies
Physicians
Resources
Support Groups
Survivor Stories
- http://www.carcinoid.org/content/survivor-stories Carcinoid/NET patients share their journeys through websites, blogs, and stories.
YouTube
- YouTube Visit our YouTube channel for videos featuring carcinoid/NET cancer specialists, patient perspectives, and conferences.
Twitter: @CarcinoidNETs
- @SNM_MI Patient Education Program in Vancouver, Canada features breakout session on #NeuroendocrineTumors. bit.ly/12voalk 23 hours ago
- RT @NETCancerDay: NET Cancer Day - 175 days to go. Celebrating Worldwide NET Cancer Awareness Day. A unique day to show the world... http:/… 2 days ago
- 26 abstracts about #carcinoid and other #NeuroendocrineTumors will be presented at the 2013 @ASCO Annual Meeting. bit.ly/10j9MP1 2 days ago
- @RareDiseases notes a #raredisease is any disease affecting fewer than 200,000 Americans. #Carcinoid and #NeuroendocrineTumors are rare. 3 days ago
- Today is International Clinical Trials Day.. @NLM_news reports that ClinicalTrials.gov has 87,184 trials in 172 countries. 3 days ago
Daily Archives: April 6, 2010
Carcinoid Syndrome Clinical Trial to Be Featured on Webcast
Lexicon Pharmaceuticals’ clinical trial LX1032 for carcinoid syndrome will be among the clinical programs that are reviewed in-depth on April 8, 2010 when the company holds its Annual R&D Day from 7:30 to 11:00 am, Eastern Time, in New York … Continue reading
Posted in carcinoid
Tagged carcinoid syndrome, clincial trials for carcinoid syndrome, clinical trials, clinical trials for cancer, H. Lee Moffitt Cancer Center and Research Institute, Hematology and Oncology Services of Little Rock, Lexicon Pharmaceuticals, M.D. Anderson Cancer Center
Leave a comment
